Tag Archives: American Academy of Neurology

GWPH Phase 3 Results

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Highlight New Epidiolex (cannabidiol) Data Released by the American Academy of Neurology

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Highlight New Epidiolex (cannabidiol) Data Released by the American Academy of Neurology

LONDON, April 18, 2017 /Weed Wire/ – GW Pharmaceuticals noted that the American Academy of Neurology (AAN) issued a press release today announcing positive results from a second Phase 3 study (GWPCARE3) of Epidiolex.

Epilepsy Study on Medical Marijuana

Epilepsy Study Examines Medical Marijuana

The American Academy of Neurology (AAN) disputes medical marijuana’s effectiveness in Medical News Today (MNT) on April 29, 2014. AAN did a comprehensive study regarding the beneficial use of marijuana based on all available evidence. While the study agreed that marijuana is a beneficial treatment for multiple sclerosis (MS), it concluded that there is not enough evidence to declare it beneficial medical treatment for epilepsy, Huntington’s disease, Tourette syndrome or cervical dystonia.


Top